Related references
Note: Only part of the references are listed.EGFR and anti-EGFR nanobodies: review and update
Jafar Sharifi et al.
JOURNAL OF DRUG TARGETING (2021)
Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer
Ravindra R. Cheruku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Click Conjugation of Boron Dipyrromethene (BODIPY) Fluorophores to EGFR-Targeting Linear and Cyclic Peptides
Tyrslai M. Williams et al.
MOLECULES (2021)
Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy
Sitanshu S. Singh et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Targeting EGFR Overexpression at the Surface of Colorectal Cancer Cells by Exploiting Amidated BODIPY-Peptide Conjugates
Tyrslai M. Williams et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2020)
Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours
Long Wang et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2020)
Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy
Vida Mashayekhi et al.
CANCERS (2020)
Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironment
Qing Zhang et al.
CANCER CELL INTERNATIONAL (2020)
EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids
Rebecca C. Feiner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancer
Man Zhang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Treatment sequencing in metastatic colorectal cancer
D. P. Modest et al.
EUROPEAN JOURNAL OF CANCER (2019)
Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
Bhuvaneshwar Vaidya et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy
Ravindra R. Cheruku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor
Nichole E. M. Kaufman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
Hanieh Hossein-Nejad-Ariani et al.
SCIENTIFIC REPORTS (2019)
Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
Weizhi Chen et al.
MOLECULAR IMAGING (2019)
Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer
Sabrina A. Maisel et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Structure-based inhibitory peptide design targeting peptide-substrate binding site in EGFR tyrosine kinase
Feria Tavakoli et al.
PLOS ONE (2019)
A Novel Conjugate of Bis[((4-bromophenyl)amino)quinazoline], a EGFR-TK Ligand, with a Fluorescent Ru(II)-Bipyridine Complex Exhibits Specific Subcellular Localization in Mitochondria
Rashid Ilmi et al.
MOLECULAR PHARMACEUTICS (2019)
Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting
Xianping Liu et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2019)
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Jesus Garcia-Foncillas et al.
FRONTIERS IN ONCOLOGY (2019)
Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Rintu Thomas et al.
FRONTIERS IN ONCOLOGY (2019)
Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy
Yanlin Feng et al.
BIOMATERIALS (2019)
Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential
Parijat Pandey et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer
Yao Yang et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Discovery of Nonpeptide, Reversible HER1/HER2 Dual-Targeting Small-Molecule Inhibitors as Near-Infrared Fluorescent Probes for Efficient Tumor Detection, Diagnostic Imaging, and Drug Screening
Shengnan Liu et al.
ANALYTICAL CHEMISTRY (2019)
CD147-mediated glucose metabolic regulation contributes to the predictive role of 18F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC
Xiaofeng Li et al.
MOLECULAR CARCINOGENESIS (2019)
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance
Atrish Bagchi et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Dual-Targeted Molecular Imaging of Cancer
Emily B. Ehlerding et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
Xilin Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics
Ruth A. Mitchell et al.
EXPERIMENTAL CELL RESEARCH (2018)
PET Imaging of Receptor Tyrosine Kinases in Cancer
Weijun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2018)
HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment
Yuzhou Shen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells
Eric Dietel et al.
ONCOGENESIS (2018)
Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2+cancer
Himgauri Naik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Inhibition of EGFR Activation by Bivalent Ligands Based on a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR
Kei Toyama et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers
Laura C. Zanetti-Domingues et al.
NATURE COMMUNICATIONS (2018)
Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides
Tyrslai M. Williams et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells
Sandeep Pallerla et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A
Sandra Markovic-Mueller et al.
STRUCTURE (2017)
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
Lee S. Rosen et al.
TARGETED ONCOLOGY (2017)
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization
Shanthi P. Kanthala et al.
ONCOTARGET (2017)
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
Javad Garousi et al.
SCIENTIFIC REPORTS (2017)
Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells
Ning Zhao et al.
BIOCONJUGATE CHEMISTRY (2017)
Affibody molecules as engineered protein drugs
Fredrik Y. Frejd et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer
Zahra Bakhtiary et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
Haiming Luo et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Targeting Angiogenesis in Colorectal Cancer Tyrosine Kinase Inhibitors
Sheetal Mehta Kircher et al.
CANCER JOURNAL (2016)
VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review)
Samanta Taurone et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules
Javad Garousi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Targeting of the epidermal growth factor receptor with mesoporphyrin IX-peptide conjugates
Krystal R. Fontenot et al.
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES (2016)
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
Marc H. A. Jansen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
Amit Singh et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Synthesis and antitumour activity of 4-aminoquinazoline derivatives
Galina N. Lipunova et al.
RUSSIAN CHEMICAL REVIEWS (2016)
Molecular basis for multimerization in the activation of the epidermal growth factor receptor
Yongjian Huang et al.
ELIFE (2016)
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance
E. Allen Sickmier et al.
PLOS ONE (2016)
Erlotinib- Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRI
Ahmed Atef Ahmed Ali et al.
SCIENTIFIC REPORTS (2016)
A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
Erika Kovacs et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
Sabrina Arena et al.
CLINICAL CANCER RESEARCH (2015)
New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy
Ezatul Ezleen Kamarulzaman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The genomic landscape of response to EGFR blockade in colorectal cancer
Andrea Bertotti et al.
NATURE (2015)
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
Friederike Braig et al.
ONCOTARGET (2015)
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
Milota Kaluzova et al.
ONCOTARGET (2015)
Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [11C]erlotinib PET
Galith Abourbeh et al.
EJNMMI RESEARCH (2015)
Monoclonal Antibody-Conjugated Superparamagnetic Iron Oxide Nanoparticles for Imaging of Epidermal Growth Factor Receptor-Targeted Cells and Gliomas
Ketao Mu et al.
MOLECULAR IMAGING (2015)
111In-Cetuximab-F(ab′)2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
Laura K. van Dijk et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Structure-Activity Relationships of Peptidomimetics that Inhibit PPI of HER2-HER3
Shanthi Kanthala et al.
BIOPOLYMERS (2014)
Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: Synthesis, characterisation and preliminary evaluation of biological activity
Liyun Ji et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors
Maxim A. Shevtsov et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
KLIFS: A Knowledge-Based Structural Database To Navigate Kinase-Ligand Interaction Space
Oscar P. J. van Linden et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors
Paul Slobbe et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Mark A. Lemmon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
Yichun Qian et al.
SCIENTIFIC REPORTS (2014)
Architecture and Membrane Interactions of the EGF Receptor
Anton Arkhipov et al.
CELL (2013)
Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis
Wei Zheng et al.
CHEMICAL COMMUNICATIONS (2013)
A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib
Feng-Ling Zhang et al.
CHEMICAL COMMUNICATIONS (2013)
Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain
Sashikanth Banappagari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculature
Saeid Zanganeh et al.
JOURNAL OF BIOMEDICAL OPTICS (2013)
Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo
Kevin Chu Foy et al.
JOURNAL OF IMMUNOLOGY (2013)
Exploring higher-order EGFR oligomerisation and phosphorylation-a combined experimental and theoretical approach
Noga Kozer et al.
MOLECULAR BIOSYSTEMS (2013)
Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma
Kristine E. Day et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Inactive ERBB Receptors Cooperate With Reactive Oxygen Species To Suppress Cancer Progression
Matthew R. Hart et al.
MOLECULAR THERAPY (2013)
Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor
S. Yoshikawa et al.
ONCOGENE (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes
Ping Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Quantitative Analysis of [11C]-Erlotinib PET Demonstrates Specific Binding for Activating Mutations of the EGFR Kinase Domain
J. Ryan Petrulli et al.
NEOPLASIA (2013)
In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptor
Maria Leonor Alvarenga et al.
ANALYTICAL BIOCHEMISTRY (2012)
Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor
Takaaki Mizuguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Recent Advances in Optical Cancer Imaging of EGF Receptors
G. Kramer-Marek et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Phthalocyanine-Peptide Conjugates for Epidermal Growth Factor Receptor Targeting
Benson G. Ongarora et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and cellular studies of PPIX-homing peptide conjugates
Martha Sibrian-Vazquez et al.
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES (2012)
Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
Yu Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods
Priyaveena Puvanakrishnan et al.
LASERS IN SURGERY AND MEDICINE (2012)
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
Clara Montagut et al.
NATURE MEDICINE (2012)
Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents
Carina Neto et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Functional Dissection of the Epidermal Growth Factor Receptor Epitopes Targeted by Panitumumab and Cetuximab
Mareike Voigt et al.
NEOPLASIA (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Toni M. Brand et al.
CANCER BIOLOGY & THERAPY (2011)
VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast et al.
CANCER RESEARCH (2011)
Immuno-imaging using nanobodies
Ilse Vaneycken et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation
Yuya Oguro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
Costas G. Hadjipanayis et al.
CANCER RESEARCH (2010)
Spatial Structure of the Transmembrane Domain Heterodimer of ErbB1 and ErbB2 Receptor Tyrosine Kinases
Konstantin S. Mineev et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor
Chafen Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study
Hyun Ju Lee et al.
LUNG CANCER (2010)
Neuropilin-1 Targeting Photosensitization-Induced Early Stages of Thrombosis via Tissue Factor Release
Denise Bechet et al.
PHARMACEUTICAL RESEARCH (2010)
Antiangiogenic Cancer Therapy: Monitoring with Molecular US and a Clinically Translatable Contrast Agent (BR55)
Marybeth A. Pysz et al.
RADIOLOGY (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
Design, Synthesis, and Docking Studies of Peptidomimetics Based on HER2-Herceptin Binding Site with Potential Antiproliferative Activity Against Breast Cancer Cell lines
Seetharama Satyanarayanajois et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging
Athanasia Bourkoula et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo
Shuxian Song et al.
FASEB JOURNAL (2009)
Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species
Yasuo Yamazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI
Ting-Jung Chen et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo
Noemie Thomas et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2009)
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Monica Red Brewer et al.
MOLECULAR CELL (2009)
Engineering of Hetero-Functional Gold Nanorods for the in vivo Molecular Targeting of Breast Cancer Cells
Mohammad Eghtedari et al.
NANO LETTERS (2009)
Structure-based view of epidermal growth factor receptor regulation
Kathryn M. Ferguson
ANNUAL REVIEW OF BIOPHYSICS (2008)
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization
Judith Schmiedel et al.
CANCER CELL (2008)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
Single-domain antibodies as building blocks for novel therapeutics
Dirk Saerens et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
David E. Gerber
DRUG DEVELOPMENT RESEARCH (2008)
Evaluation of [F-18]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors
Helen Su et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Predominance of activated EGFR higher-order oligomers on the cell surface
Andrew H. A. Clayton et al.
GROWTH FACTORS (2008)
Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice
Noemie Thomas et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2008)
Properties, production, and applications of camelid single-domain antibody fragments
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the Anti-EGFR monoclonal antibody cetuximab
Yang Lu et al.
CANCER RESEARCH (2007)
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
Hideharu Kimura et al.
CANCER SCIENCE (2007)
The direct effects of anti-vascular endothelial growth factor therapy on tumor cells
Christian Moser et al.
CLINICAL COLORECTAL CANCER (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors
Jeffrey Jie-Lou Liao
JOURNAL OF MEDICINAL CHEMISTRY (2007)
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Xuewu Zhang et al.
CELL (2006)
Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain
FT Huang et al.
MOLECULAR CELL (2006)
Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
Girolamo Ranieri et al.
CURRENT MEDICINAL CHEMISTRY (2006)
[177Lu]pertuzumab:: experimental studies on targeting of HER-2 positive tumour cells
M Persson et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
ZH Li et al.
FASEB JOURNAL (2005)
Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis
AHA Clayton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Immunotargeted nanoshells for integrated cancer imaging and therapy
C Loo et al.
NANO LETTERS (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using In-111-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function
D Mattoon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2
RZ Renno et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Synthesis of AX7593, a quinazoline-derived photoaffinity probe for EGFR
KR Shreder et al.
ORGANIC LETTERS (2004)
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D Artemov et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson et al.
MOLECULAR CELL (2003)
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
XY Wu et al.
NATURE BIOTECHNOLOGY (2003)
Preliminary study on radioimmunodiagnosis of experimental tumor models using technetium-99m-labeled anti-C-erbB-2 monoclonal antibody
A Meenakshi et al.
TUMORI JOURNAL (2002)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Disabling receptor ensembles with rationally designed interface peptidomimetics
A Berezov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
